These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1289111)

  • 21. A decomposition product of a contaminant implicated in L-tryptophan eosinophilia myalgia syndrome affects spinal cord neuronal cell death and survival through stereospecific, maturation and partly interleukin-1-dependent mechanisms.
    Brenneman DE; Page SW; Schultzberg M; Thomas FS; Zelazowski P; Burnet P; Avidor R; Sternberg EM
    J Pharmacol Exp Ther; 1993 Aug; 266(2):1029-35. PubMed ID: 8355179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The eosinophilia-myalgia syndrome: lessons from Germany.
    Mayeno AN; Gleich GJ
    Mayo Clin Proc; 1994 Jul; 69(7):702-4. PubMed ID: 8015338
    [No Abstract]   [Full Text] [Related]  

  • 23. The eosinophilia-myalgia syndrome revisited.
    Belongia EA; Gleich GJ
    J Rheumatol; 1996 Oct; 23(10):1682-5. PubMed ID: 8895139
    [No Abstract]   [Full Text] [Related]  

  • 24. Eosinophilia-myalgia syndrome: lessons for public health researchers.
    Taylor R; McNeil JJ
    Med J Aust; 1993 Jan; 158(1):51-5. PubMed ID: 8380218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contaminants in L-tryptophan associated with eosinophilia myalgia syndrome.
    Hill RH; Caudill SP; Philen RM; Bailey SL; Flanders WD; Driskell WJ; Kamb ML; Needham LL; Sampson EJ
    Arch Environ Contam Toxicol; 1993 Jul; 25(1):134-42. PubMed ID: 8346973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Eosinophilia-myalgia: new syndrome].
    Szechiński J; Borysewicz K
    Postepy Hig Med Dosw; 1992; 46(3):319-25. PubMed ID: 1369828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eosinophilia-myalgia syndrome in Wisconsin.
    Butler JC; Davis JP
    Wis Med J; 1990 Dec; 89(12):687-91. PubMed ID: 2293489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiologic studies of the association of L-tryptophan with the eosinophilia-myalgia syndrome: a critique.
    Shapiro S
    J Rheumatol Suppl; 1996 Oct; 46():44-58; discussion 58-9. PubMed ID: 8895181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eosinophilia-myalgia syndrome in L-tryptophan-exposed patients.
    Kamb ML; Murphy JJ; Jones JL; Caston JC; Nederlof K; Horney LF; Swygert LA; Falk H; Kilbourne EM
    JAMA; 1992 Jan; 267(1):77-82. PubMed ID: 1727200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural characterization of contaminants found in commercial preparations of melatonin: similarities to case-related compounds from L-tryptophan associated with eosinophilia-myalgia syndrome.
    Williamson BL; Tomlinson AJ; Mishra PK; Gleich GJ; Naylor S
    Chem Res Toxicol; 1998 Mar; 11(3):234-40. PubMed ID: 9544622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eosinophilia-myalgia syndrome associated with L-tryptophan. A case report with pulmonary manifestations and review of the literature.
    André M; Canon JL; Levecque P; Dermine P; Mortier C; Leveau F
    Acta Clin Belg; 1991; 46(3):178-82. PubMed ID: 1656679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 1,1'-Ethylidenebis[L-tryptophan], an impurity in L-tryptophan associated with eosinophilia-myalgia syndrome, stimulates type I collagen gene expression in human fibroblasts in vitro.
    Zangrilli JG; Mayeno AN; Vining V; Varga J
    Biochem Mol Biol Int; 1995 Nov; 37(5):925-33. PubMed ID: 8624499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An investigation of the cause of the eosinophilia-myalgia syndrome associated with tryptophan use.
    Belongia EA; Hedberg CW; Gleich GJ; White KE; Mayeno AN; Loegering DA; Dunnette SL; Pirie PL; MacDonald KL; Osterholm MT
    N Engl J Med; 1990 Aug; 323(6):357-65. PubMed ID: 2370887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The eosinophilia-myalgia syndrome and eosinophilic fasciitis.
    Jimenez SA; Varga J
    Curr Opin Rheumatol; 1991 Dec; 3(6):986-94. PubMed ID: 1772754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eosinophilia-myalgia syndrome in patients ingesting a single source of L-tryptophan.
    Henning KJ; Jean-Baptiste E; Singh T; Hill RH; Friedman SM
    J Rheumatol; 1993 Feb; 20(2):273-8. PubMed ID: 8474064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eosinophilia myalgia syndrome.
    Blackburn WD
    Semin Arthritis Rheum; 1997 Jun; 26(6):788-93. PubMed ID: 9213377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia.
    Bolster MB; Silver RM
    Curr Opin Rheumatol; 1994 Nov; 6(6):642-9. PubMed ID: 7865387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia.
    Silver RM
    Curr Opin Rheumatol; 1992 Dec; 4(6):851-6. PubMed ID: 1457280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Continuing occurrence of eosinophilia myalgia syndrome in Canada.
    Spitzer WO; Haggerty JL; Berkson L; Davis W; Palmer W; Tamblyn R; Laprise R; Faith JM; Elmore JG; Horwitz RI
    Br J Rheumatol; 1995 Mar; 34(3):246-51. PubMed ID: 7728400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The natural history of eosinophilia-myalgia syndrome in a tryptophan-exposed cohort in South Carolina.
    Sullivan EA; Kamb ML; Jones JL; Meyer P; Philen RM; Falk H; Sinks T
    Arch Intern Med; 1996 May; 156(9):973-9. PubMed ID: 8624177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.